foxo4-dri p53 The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Figure 4 FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging Analysis of the 2 predicted binding pockets of FOXO4 DRI. (A) Surface Download Scientific Diagram FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI For Sale (10mg) Core Peptides FOXO4 DRI 10mg (Proxofim) River Peptides Ltd
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30





